| Application no. and date | 20193183.9 (espacenet) (Federated) (European Patent Register), 20170510 | | Patent/reg. no. and date | DK/EP 3792628, 20240424 | | Publication date | 20210317 | | Priority no. and date | WO PCT/EP2016/060897, 20160513 | | EP pub. no. and date |
EP 3792628 20210317 | | Effective date | | | Applicant/owner | TRON - Translationale Onkologie an der
Universitätsmedizin der Johannes Gutenberg-
Universität Mainz gemeinnützige GmbH, Freiligrathstrasse 12
55131 Mainz, DE,
BioNTech SE, An der Goldgrube 12
55131 Mainz, DE | | Applicant ref. no. | V2405-004-DK | | Inventor | SAHIN, Ugur, Philipp-von-Zabern-Platz 1
55116 Mainz, DE,
VORMEHR, Mathias, Alexander-Diehl-StraÃYe 10
55130 Mainz, DE,
LÖWER, Martin, Franziska-Kessel-StraÃYe 61
55131 Mainz, DE,
BOEGEL, Sebastian, BergstraÃYe 13
67823 Obermoschel, DE,
SCHRÖRS, Barbara, Kapellenstr. 34
55124 Mainz, DE | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | G01N 33/50 (2006.01) , G01N 33/53 (2006.01) , G01N 33/68 (2006.01) | | Title | FREMGANGSMÅDER TIL FORUDSIGELSE AF NEOANTIGENERS ANVENDELIGHED TIL IMMUNTERAPI | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
